FAFernando Gomes de Almeida

Fernando Gomes de Almeida

*This is an algorithmically generated author record based on publicly available information.

Fernando Gomes de Almeida has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A face "Janus" dos canabinoides sintéticos

    by Lívia Pinto Pinheiro, Fernando Almeida, Regina Kubrusly

    Os canabinoides sintéticos (CS) surgiram originalmente como ferramentas farmacológicas para o estudo dos efeitos da Cannabis e do Sistema Endocanabinoide, mas foram incorporados pelo mercado ilícito para uso recreativo e transformados em potentes drogas de abuso. Comercializados em diversas apresentações e sob nomenclaturas populares variadas, essas substâncias possuem elevada potência e toxicidade, podendo provocar efeitos adversos graves e multissistêmicos, e desafiando as instituições de saúde e segurança. O presente artigo aborda essa dualidade dos CS, revisando sua evolução histórica, características químicas, formas de consumo e impactos fisiológicos e toxicológicos, com foco no Sistema Nervoso, além do panorama regulatório e epidemiológico no Brasil. Embora permaneçam relevantes como ferramentas de pesquisa científica e por seu potencial terapêutico, os CS representam uma importante ameaça à saúde pública quando utilizados como drogas recreativas. Nesse cenário, a integração entre setores científicos, regulatórios, de segurança, de saúde e de educação pública torna-se fundamental para acompanhar a rápida transformação dessas substâncias e reduzir seus impactos sobre a sociedade.

  • Pharmaceutical Evaluation of Medical Cannabis Extracts Prepared by Artisanal and Laboratory Techniques

    by Virgínia Martins Carvalho, Juliana dos Santos Carmo, Lisia Maria Gobbo dos Santos, Fernando Gomes de Almeida, Ernesto Díaz Rocha, Ana Cláudia de Macêdo Vieira, Joana Angélica Barbosa Ferreira, Silvana Do Couto Jacob, Robert M. Strongin, Antonio Jorge Ribeiro da Silva


  • Facing the Forensic Challenge of Cannabis Regulation: A Methodology for the Differentiation between Hemp and Marijuana Samples / Presumptive and confirmatory methods for hemp and marijuana analysis

    by Virgínia Carvalho, Fernando de Almeida, Andrey de Aguiar, Fernanda Pereira, Ernesto Rocha

    Access to medical and recreational cannabis has been regulated in several countries. Cannabinoids are secondary metabolites used as chemical markers of Cannabis genus plants. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the most abundant cannabinoids and their proportion is used to differentiate hemp (THC/CBD1) varieties. Brazilian sanitary regulations permit prescription, importation and sale of cannabis-derived products by pharmaceuticals distributors and drugstores, even though their crops are still prohibited, and the current scenario is characterized by marijuana trafficking, legal trade of medical cannabis products, and cultivation and production of cannabis-derived products by patients and non-governmental organizations (NGOs), with or without judicial authorizations. Medical cannabis regulation is in progress and there is an urgent need to implement analytical methods for monitoring the chemical profile of cannabis crops. Thus, the goal of the present study was to propose a methodology based on presumptive and confirmatory methods to differentiate the two principal chemovars of Cannabis genus plants, i.e., CBD-rich (hemp) and THC-rich (marijuana). A color test and a validated high-performance liquid chromatography (HPLC) method were applied to six cannabis samples cultivated by patients with judicial authorization. The methodology proved to be useful for forensic purposes and for quality control of medical cannabis. Plants cultivated by patients showed three profiles, classified as THC-rich, CBD-rich and approximately 1:1 THC/CBD ratio.